Report cover image

Europe Dyspepsia Drug Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published May 01, 2023
Length 399 Pages
SKU # DAABD18011502

Description

Europe Dyspepsia Drug Market - Industry Trends and Forecast to 2030


Europe dyspepsia drug market is expected to reach USD 302,156.89 thousand by 2030 from USD 211,124.34 thousand in 2022, growing at a CAGR of 4.7% during the forecast period of 2023 to 2030.
Market Segmentation:
Europe Dyspepsia Drug Market, By Type (Organic Dyspepsia, Non-Ulcer Dyspepsia, Drug Induced Dyspepsia, and Others), Treatment Type (Medication and Surgery), Drug Type (Branded and Generic), Prescription (Without Prescription Drugs and Prescription Drugs), Route of Administration (Oral and Injectable), Gender (Male and Female), End-User (Hospitals, Clinics, Homecare settings, Specialty Clinics, Ambulatory Surgical Centers, Academic and Government Research Institutes, and Others), Distribution Channel (Direct Tender and Retail Sales), Country ( Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Denmark, Sweden, Poland, Norway, Finland, and Rest of Europe) - Industry Trends and Forecast to 2030



Overview of Europe Dyspepsia Drug Market Dynamics:

Driver
• Increasing prevalence of dyspepsia

Restrain

• Possible side effects of the drugs used for dyspepsia

Opportunity

• Growing aging population


Market Players:

Some of the key market players operating in the Europe dyspepsia drug market are listed below:

• Abbott
• Bayer AG
• Cadila Pharmaceuticals
• Sanofi
• Lupin
• Perrigo Company plc
• Reckitt Benckiser
• AstraZeneca
• Procter & Gamble
• Otsuka Pharmaceutical Co., Ltd.
• Others


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

399 Pages
1 Introduction 85
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Dyspepsia Drug Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation 91
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 Market End-user Coverage Grid
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary 104
4 Premium Insight 107
4.1 Pestel Analysis
4.2 Porter’s Five Forces
5 Epidemiology 110
6 Problems In The Management Of Dyspepsia 111
7 Industry Insights: 112
8 Europe Dyspepsia Drug Market, Regulation 113
9 Market Overview 116
9.1 Drivers
9.1.1 Increasing Prevalence Of Dyspepsia
9.1.2 Rise In The Adoption Of Unhealthy Lifestyle
9.1.3 Increase In The Prevalence Of Metabolic Disorders
9.2 Restraints
9.2.1 Possible Side Effects Of The Drugs Used For Dyspepsia
9.2.2 Increasing Preference For Natural And Herbal Remedies
9.3 Opportunities
9.3.1 Growing Aging Population
9.3.2 Rise In The Drug Approval
9.4 Challenges
9.4.1 Lack Of Awareness About Dyspepsia Among The Population
9.4.2 Stringent Regulations
10 Europe Dyspepsia Drug Market, By Type 124
10.1 Overview
10.2 Non-ulcer Dyspepsia
10.3 Organic Dyspepsia
10.4 Drug Induced Dyspepsia
10.5 Others
11 Europe Dyspepsia Drug Market, By Treatment Type 131
11.1 Overview
11.2 Medication
11.2.1 Drugs
11.2.1.1 Antacids
11.2.1.1.1 Proton Pump Inhibitors (Ppi’s)
11.2.1.1.1.1 Omeprazole
11.2.1.1.1.2 Lansoprazole
11.2.1.1.1.3 Esomeprazole
11.2.1.1.1.4 Others
11.2.1.1.2 H2 Blockers
11.2.1.1.2.1 Cimetidine
11.2.1.1.2.2 Famotidine
11.2.1.1.2.3 Nizatidine
11.2.1.1.2.4 Ranitidine
11.2.1.1.2.5 Others
11.2.1.2 Gastric Prokinetic Gendernts
11.2.1.2.1 Mosapride Citrate
11.2.1.2.2 Metoclopramide
11.2.1.2.3 Cisapride
11.2.1.2.4 Itopride Hydrochloride
11.2.1.2.5 Domperidone
11.2.1.2.6 Others
11.2.1.3 Antibiotics
11.2.1.3.1 Refaximin
11.2.1.3.2 Amoxicillin
11.2.1.3.3 Clarithromycin
11.2.1.3.4 Metronidazole
11.2.1.3.5 Levofloxacin
11.2.1.3.6 Tetracycline
11.2.1.3.7 Others
11.2.1.4 Others
11.2.2 Non- Drugs
11.2.2.1 Probiotics
11.2.2.1.1 Lactobacillus
11.2.2.1.2 Bifidobacterium
11.2.2.1.3 Bacillus
11.2.2.1.4 Streptococcus
11.2.2.1.5 Others
11.2.2.2 Prebiotics
11.3 Surgery
12 Europe Dyspepsia Drug Market, By Drug Type 144
12.1 Overview
12.2 Generic
12.3 Branded
13 Europe Dyspepsia Drug Market, By Prescription 150
13.1 Overview
13.2 Without Prescription Drugs
13.3 Prescription Drugs
14 Europe Dyspepsia Drug Market, By Route Of Administration 156
14.1 Overview
14.2 Oral
14.2.1 Tablets
14.2.2 Capsules
14.3 Injectable
15 Europe Dyspepsia Drug Market, By Gender 162
15.1 Overview
15.2 Female
15.2.1 30-50 Years
15.2.2 More Than 50 Years
15.2.3 Age Less Than 30
15.3 Male
15.3.1 30-50 Years
15.3.2 More Than 50 Years
15.3.3 Age Less Than 30
16 Europe Dyspepsia Drug Market, By End User 169
16.1 Overview
16.2 Hospitals
16.2.1 Type
16.2.1.1 Public
16.2.1.2 Private
16.2.2 Tier
16.2.2.1 Tier 3
16.2.2.2 Tier 2
16.2.2.3 Teir 1
16.3 Clinics
16.4 Homecare Settings
16.5 Specialty Clinics
16.6 Ambulatory Centers
16.7 Academic And Government Research Institutes
16.8 Others
17 Europe Dyspepsia Drug Market, By Distribution Channel 179
17.1 Overview
17.2 Retail Sales
17.2.1 Reatil Pharmacy
17.2.2 Hospital Pharmacy
17.2.3 Online Pharmacy
17.3 Direct Tender
18 Europe Dyspepsia Drug Market, By Region 185
18.1 Europe
18.1.1 Germany
18.1.2 U.K.
18.1.3 Italy
18.1.4 France
18.1.5 Spain
18.1.6 Russia
18.1.7 Switzerland
18.1.8 Turkey
18.1.9 Belgium
18.1.10 Netherlands
18.1.11 Denmark
18.1.12 Sweden
18.1.13 Poland
18.1.14 Norway
18.1.15 Finland
18.1.16 Rest Of Europe
19 Europe Dyspepsia Drug Market, Company Landscape 351
19.1 Company Share Analysis: Europe
20 Swot Analysis 352
21 Europe Dyspepsia Drug Market, Company Profilings 353
21.1 Sanofi
21.1.1 Company Snapshot
21.1.2 Revenue Analysis
21.1.3 Company Share Analysis
21.1.4 Product Portfolio
21.1.5 Recent Development
21.2 Lupin
21.2.1 Company Snapshot
21.2.2 Revenue Analysis
21.2.3 Company Share Analysis
21.2.4 Product Portfolio
21.2.5 Recent Developments
21.3 Mankind Pharma
21.3.1 Company Snapshot
21.3.2 Revenue Analysis
21.3.3 Company Share Analysis
21.3.4 Product Portfolio
21.3.5 Recent Development
21.4 Astrazeneca
21.4.1 Company Snapshot
21.4.2 Revenue Analysis
21.4.3 Company Share Analysis
21.4.4 Product Portfolio
21.4.5 Recent Development
21.5 Bayer Ag
21.5.1 Company Snapshot
21.5.2 Revenue Analysis
21.5.3 Company Share Analysis
21.5.4 Product Portfolio
21.5.5 Recent Development
21.6 Abbott
21.6.1 Company Snapshot
21.6.2 Revenue Analysis
21.6.3 Product Portfolio
21.6.4 Recent Development
21.7 Ani Pharmaceuticals, Inc.
21.7.1 Company Snapshot
21.7.2 Revenue Analysis
21.7.3 Product Portfolio
21.7.4 Recent Development
21.8 Aosaikang Pharmaceutical Co., Ltd.
21.8.1 Company Snapshot
21.8.2 Revenue Analysis
21.8.3 Product Portfolio
21.8.4 Recent Development
21.9 Asterisk Laboratories (I) Pvt. Ltd
21.9.1 Company Snapshot
21.9.2 Product Portfolio
21.9.3 Recent Development
21.10 Cadila Pharmaceuticals
21.10.1 Company Snapshot
21.10.2 Revenue Analysis
21.10.3 Company Share Analysis
21.10.4 Product Portfolio
21.10.5 Recent Development
21.11 Hanmi Pharm. Co., Ltd.
21.11.1 Company Snapshot
21.11.2 Revenue Analysis
21.11.3 Product Portfolio
21.11.4 Recent Development
21.12 Mcneil Consumer Pharmaceuticals Co. (A Subsidiary Of Johnson & Johnson Services, Inc.)
21.12.1 Company Snapshot
21.12.2 Revenue Analysis
21.12.3 Product Portfolio
21.12.4 Recent Development
21.13 Otsuka Pharmaceutical Co., Ltd.
21.13.1 Company Snapshot
21.13.2 Revenue Analysis
21.13.3 Product Portfolio
21.13.4 Recent Development
21.14 Perrigo Company Plc
21.14.1 Company Snapshot
21.14.2 Revenue Analysis
21.14.3 Product Portfolio
21.14.4 Recent Development
21.15 Prestige Consumer Healthcare, Inc.
21.15.1 Company Snapshot
21.15.2 Revenue Analysis
21.15.3 Product Portfolio
21.15.4 Recent Development
List Of Tables
Table 1 Europe Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 2 Europe Non-ulcer Dyspepsia In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 3 Europe Organic Dyspepsia In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 4 Europe Drug Induced Dyspepsia In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 5 Europe Others In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 6 Europe Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 7 Europe Medication In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 8 Europe Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 9 Europe Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 10 Europe Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 11 Europe Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 12 Europe H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 13 Europe Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 14 Europe Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 15 Europe Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 16 Europe Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 17 Europe Surgery In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 18 Europe Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 19 Europe Generic In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 20 Europe Branded In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 21 Europe Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand)
Table 22 Europe Without Prescription Drugs In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 23 Europe Prescription Drugs In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 24 Europe Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 25 Europe Oral In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 26 Europe Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 27 Europe Injectable In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 28 Europe Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand)
Table 29 Europe Female In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 30 Europe Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 31 Europe Male In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 32 Europe Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 33 Europe Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand)
Table 34 Europe Hospitals In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 35 Europe Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 36 Europe Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand)
Table 37 Europe Clinics In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 38 Europe Homecare Settings In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 39 Europe Specialty Clinics In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 40 Europe Ambulatory Centers In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 41 Europe Academic And Government Research Institutes In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 42 Europe Others In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 43 Europe Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 44 Europe Retail Sales In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 45 Europe Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 46 Europe Direct Tender In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 47 Europe Dyspepsia Drug Market, By Country, 2021-2030 (Usd Thousand)
Table 48 Europe Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 49 Europe Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 50 Europe Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 51 Europe Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 52 Europe Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 53 Europe Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 54 Europe Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 55 Europe H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 56 Europe H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 57 Europe Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 58 Europe Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 59 Europe Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 60 Europe Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 61 Europe Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 62 Europe Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 63 Europe Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 64 Europe Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 65 Europe Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 66 Europe Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 67 Europe Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand)
Table 68 Europe Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 69 Europe Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 70 Europe Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand)
Table 71 Europe Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 72 Europe Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 73 Europe Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand)
Table 74 Europe Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 75 Europe Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand)
Table 76 Europe Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 77 Europe Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 78 Germany Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 79 Germany Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 80 Germany Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 81 Germany Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 82 Germany Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 83 Germany Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 84 Germany Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 85 Germany Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 86 Germany H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 87 Germany H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 88 Germany H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 89 Germany Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 90 Germany Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 91 Germany Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 92 Germany Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 93 Germany Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 94 Germany Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 95 Germany Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 96 Germany Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 97 Germany Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 98 Germany Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 99 Germany Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 100 Germany Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand)
Table 101 Germany Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 102 Germany Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 103 Germany Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand)
Table 104 Germany Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 105 Germany Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 106 Germany Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand)
Table 107 Germany Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 108 Germany Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand)
Table 109 Germany Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 110 Germany Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 111 U.K. Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 112 U.K. Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 113 U.K. Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 114 U.K. Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 115 U.K. Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 116 U.K. Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 117 U.K. Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 118 U.K. Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 119 U.K. H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 120 U.K. H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 121 U.K. H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 122 U.K. Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 123 U.K. Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 124 U.K. Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 125 U.K. Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 126 U.K. Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 127 U.K. Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 128 U.K. Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 129 U.K. Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 130 U.K. Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 131 U.K. Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 132 U.K. Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 133 U.K. Branded In Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 134 U.K. Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand)
Table 135 U.K. Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 136 U.K. Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 137 U.K. Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand)
Table 138 U.K. Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 139 U.K. Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 140 U.K. Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand)
Table 141 U.K. Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 142 U.K. Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand)
Table 143 U.K. Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 144 U.K. Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 145 Italy Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 146 Italy Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 147 Italy Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 148 Italy Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 149 Italy Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 Europe Dyspepsia Drug Market: Segmentation
Figure 2 Europe Dyspepsia Drug Market: Data Triangulation
Figure 3 Europe Dyspepsia Drug Market: Droc Analysis
Figure 4 Europe Dyspepsia Drug Market: Europe Vs. Regional Market Analysis
Figure 5 Europe Dyspepsia Drug Market: Company Research Analysis
Figure 6 Europe Dyspepsia Drug Market: Interview Demographics
Figure 7 Europe Dyspepsia Drug Market: Multivariate Modelling
Figure 8 Europe Dyspepsia Drug Market: Dbmr Market Position Grid
Figure 9 Europe Dyspepsia Drug Market: Vendor Share Analysis
Figure 10 Europe Dyspepsia Drug Market: Market End-user Coverage Grid
Figure 11 Europe Dyspepsia Drug Market: Segmentation
Figure 12 Increase In The Prevalence Of Metabolic Disorders Is Expected To Drive The Europe Dyspepsia Drug Market Growth In The Forecast Period From 2023 To 2030
Figure 13 Non-ulcer Dyspepsia Segment Is Expected To Account For The Largest Share Of The Europe Dyspepsia Drug Market In 2023 & 2030
Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The Europe Dyspepsia Drug Market
Figure 15 Europe Dyspepsia Drug Market: By Type, 2022
Figure 16 Europe Dyspepsia Drug Market: By Type, 2023-2030 (Usd Thousand)
Figure 17 Europe Dyspepsia Drug Market: By Type, Cagr (2023-2030)
Figure 18 Europe Dyspepsia Drug Market: By Type, Lifeline Curve
Figure 19 Europe Dyspepsia Drug Market: By Treatment Type , 2022
Figure 20 Europe Dyspepsia Drug Market: By Treatment Type, 2023-2030 (Usd Thousand)
Figure 21 Europe Dyspepsia Drug Market: By Treatment Type , Cagr (2023-2030)
Figure 22 Europe Dyspepsia Drug Market: By Treatment Type , Lifeline Curve
Figure 23 Europe Dyspepsia Drug Market: By Drug Type, 2022
Figure 24 Europe Dyspepsia Drug Market: By Drug Type, 2023-2030 (Usd Thousand)
Figure 25 Europe Dyspepsia Drug Market: By Drug Type, Cagr (2023-2030)
Figure 26 Europe Dyspepsia Drug Market: By Drug Type, Lifeline Curve
Figure 27 Europe Dyspepsia Drug Market: By Prescription, 2022
Figure 28 Europe Dyspepsia Drug Market: By Prescription, 2023-2030 (Usd Thousand)
Figure 29 Europe Dyspepsia Drug Market: By Prescription, Cagr (2023-2030)
Figure 30 Europe Dyspepsia Drug Market: By Prescription, Lifeline Curve
Figure 31 Europe Dyspepsia Drug Market: By Route Of Administration, 2022
Figure 32 Europe Dyspepsia Drug Market: By Route Of Administration, 2023-2030 (Usd Thousand)
Figure 33 Europe Dyspepsia Drug Market: By Route Of Administration, Cagr (2023-2030)
Figure 34 Europe Dyspepsia Drug Market: By Route Of Administration, Lifeline Curve
Figure 35 Europe Dyspepsia Drug Market: By Gender, 2022
Figure 36 Europe Dyspepsia Drug Market: By Gender, 2023-2030 (Usd Thousand)
Figure 37 Europe Dyspepsia Drug Market: By Gender, Cagr (2023-2030)
Figure 38 Europe Dyspepsia Drug Market: By Gender, Lifeline Curve
Figure 39 Europe Dyspepsia Drug Market: By End User, 2022
Figure 40 Europe Dyspepsia Drug Market: By End User, 2023-2030 (Usd Thousand)
Figure 41 Europe Dyspepsia Drug Market: By End User, Cagr (2023-2030)
Figure 42 Europe Dyspepsia Drug Market: By End User, Lifeline Curve
Figure 43 Europe Dyspepsia Drug Market: By Distribution Channel, 2022
Figure 44 Europe Dyspepsia Drug Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 45 Europe Dyspepsia Drug Market: By Distribution Channel, Cagr (2023-2030)
Figure 46 Europe Dyspepsia Drug Market: By Distribution Channel, Lifeline Curve
Figure 47 Europe Dyspepsia Drug Market: Snapshot (2022)
Figure 48 Europe Dyspepsia Drug Market: By Country (2022)
Figure 49 Europe Dyspepsia Drug Market: By Country (2023 & 2030)
Figure 50 Europe Dyspepsia Drug Market: By Country (2022 & 2030)
Figure 51 Europe Dyspepsia Drug Market: By Type (2023-2030)
Figure 52 Europe Dyspepsia Drug Market: Compa

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us